Breast Cancer Risk: It’s More Than Family History
May 22, 2023
GeneType for breast cancer provides a personalized risk score to help you and your healthcare provider develop a risk reduction plan just for you.
One in eight women will develop breast cancer over her lifetime and most will have no significant family history of the disease. In fact, 85% of all breast cancers are non-hereditary and sporadic. Whether you have high, medium, or low risk, you can always take some risk reduction actions such as lifestyle modification, breast mammography, or taking risk-reducing medication. So how do you know if you’re at risk?
GeneType for Breast Cancer is a simple saliva test your healthcare provider can order, and it is the only test that gives you a comprehensive and highly accurate risk prediction score based on common genetic factors with traditional risk markers.
While only 1 in 400 women will have a BRCA mutation, this test is for the other 399 women to know if they are at an increased risk of getting breast cancer or not. GeneType provides a risk assessment test report, which is a straightforward interpretation of the risk score results and allows us to communicate the results to patients.
PROMOTED
NeurAxis is dedicated to making sure those who need IB-Stim have access to this safe and effective non-drug alternative for Functional Abdominal Pain due to Irritable Bowel Syndrome in patients aged 11-18 years old.
PROMOTED
Solution for functional abdominal pain due to IBS in teenagers, and professional childcare services at Alvey’s Education.
PROMOTED
The annual Country Music Awards show took place last night at the Moody Center in Austin Texas. The award show aired live on CBS and streamed on Paramount+. Kelsea Ballerini hosted the show and country music’s biggest stars attended. The CMT Music Awards had first-time nominees including Amber Riley, Ashley Cooke, Bret Michaels, Chayce Beckham, Hozier, Koe Wetzel, Stephen […]
